Utility of PET-CT on radiotherapy planning of head and neck cancer. Our initial experience

被引:5
|
作者
Bellon Guardia, M. E. [1 ]
Perez Romasanta, L. [2 ]
Garcia Vicente, A. M. [1 ]
Talavera Rubio, M. P. [1 ]
Palomar Munoz, A. [1 ]
Gonzalez Garcia, B. [1 ]
Poblete Garcia, V. M. [1 ]
Soriano Castrejon, A. [1 ]
机构
[1] Hosp Gen Ciudad Real, Nucl Med Serv, Ciudad Real, Spain
[2] Hosp Gen Ciudad Real, Serv Oncol Radioterap, Ciudad Real, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR | 2010年 / 29卷 / 04期
关键词
Radiotherapy planning; Head and neck tumors; Positron emission tomography-computed tomography; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; GROSS TUMOR VOLUME; FDG-PET; COMPUTED-TOMOGRAPHY; FLUORO-DEOXYGLUCOSE; RECURRENT HEAD; IMPACT; SEGMENTATION; DEFINITION;
D O I
10.1016/j.remn.2010.03.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To describe the methods used for the incorporation of FDG-PET-CT on radiotherapy planning of patients with head and neck cancer and also to evaluate the impact of FOG-PET-CT on staging and tumor volume definition. Material and methods: A prospective study in which 20 patients with head and neck tumor submitted for radiotherapy treatment were included. All underwent a whole body PET- CT (GE DSTE 16) for staging and restaging, also acquiring an additional 3 h delayed PET image with diagnostic CT parameters for planning. A CT scan with diagnostic protocol. tabletop available for radiotherapy treatment and the same personalized head-shoulder mask were used in the latter. Lymph node involvement and/or distant involvement were evaluated, considering the changes in staging. We also evaluated the differences in volumes obtained between the different techniques. The threshold value used for delineating PET gross tumor volume (GTV) was empirically established and ranged from 20-40% of the maximum SUV. Results: Radiotherapy planning was performed with PET-CT in 20 patients between October 2007 to September 2008. A total of 29 lesions (18 primary lesions because 2 patients were excluded as no tumor was observed on the PET CT images, and 11 nodes). The most frequent location was oropharynx (5 patients). Mean maxSUV of the 29 lesions was 14.4 (range 5.0 and 26.4). No statistically significant differences were found between the GTV PET and GTV CT (mean 21.9 cm(3) and 19.3 cm(3), respectively). PET-CT modified the staging in 20% of the patients, with a diagnostic and therapeutic impact of 50 and 25%, respectively. Conclusion: The incorporation of PET-CT in routine radiotherapy planning is a promising technique that requires close collaboration between the nuclear medicine and radiotherapy oncology departments. PET-CT achieves better staging in patients and has a significant diagnostic and therapeutic impact. The use of the hybrid technique avoids problems arising from co-registry as well as a second examination for planning with the consequent advantage for the patient. Nonetheless, more prospective and randomized studies with pathology specimens are needed to evaluate the real impact in the tumor volume definition. (C) 2009 Elsevier Espana, S.L. and SEMNIM. All rights reserved.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [42] PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer
    Mehanna, Hisham
    Wong, Wai-Lup
    McConkey, Christopher C.
    Rahman, Joy K.
    Robinson, Max
    Hartley, Andrew G. J.
    Nutting, Christopher
    Powell, Ned
    Al-Booz, Hoda
    Robinson, Martin
    Junor, Elizabeth
    Rizwanullah, Mohammed
    von Zeidler, Sandra V.
    Wieshmann, Hulya
    Hulme, Claire
    Smith, Alison F.
    Hall, Peter
    Dunn, Janet
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (15): : 1444 - 1454
  • [43] Therapeutic optimization in head and neck radiotherapy planning: Advocacy for 18FDG PET-CT in treatment condition
    Nevesny, Stephane
    Flaus, Antime
    Ailloud, Antoine
    Sotton, Sandrine
    Prevot, Nathalie
    Guy, Jean-Baptiste
    Magne, Nicolas
    BULLETIN DU CANCER, 2022, 109 (12) : 1262 - 1268
  • [44] Imaging and PET-CT of head and neck cancers
    Maunoury, C.
    Halimi, P.
    JOURNAL DE RADIOLOGIE, 2008, 89 (03): : 403 - 412
  • [45] The impact of PET-CT registration in IMRT-Planning for head and neck cancers
    Iotti, C.
    Versari, A.
    Paiusco, M.
    Iori, M.
    Polico, R.
    Palmieri, T.
    D'Abbiero, N.
    De Marco, G.
    Romeo, A.
    Armaroli, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S422 - S423
  • [46] PET-CT for head and neck IMRT planning: Target delineation and dose escalation
    Gillis, A.
    Hwang, A.
    Teo, K.
    Bacharach, S.
    Bucci, M.
    Millender, L.
    Schechter, N.
    Quivey, J.
    Franc, B.
    Xia, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S457 - S457
  • [47] Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours
    Troost, Esther G. C.
    Schinagl, Dominic A. X.
    Bussink, Johan
    Oyen, Wim J. G.
    Kaanders, Johannes H. A. M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 (03) : 328 - 334
  • [48] Role of PET/CT in Treatment Planning for Head and Neck Cancer Patients Undergoing Definitive Radiotherapy
    Arslan, Sonay
    Abakay, Candan Demiroz
    Sen, Feyza
    Altay, Ali
    Akpinar, Tayyar
    Ekinci, Ahmet Siyar
    Esbah, Onur
    Uslu, Nuri
    Kekilli, Kezban Esra
    Ozkan, Lutfi
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10899 - 10903
  • [49] PET-CT IN RADIOTHERAPY PLANNING: A TECHNOLOGIST PERSPECTIVE
    MacFarlane, L.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 27 - 27
  • [50] Comparison of CT and FDG-PET for Target Delineation of Head and Neck Cancer in Radiotherapy Planning
    Kajitani, C.
    Asakawa, I.
    Okada, H.
    Katayama, E.
    Tamamoto, T.
    Shinkai, T.
    Uto, F.
    Maekura, T.
    Tsushima, J.
    Hasegawa, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S426 - S426